Gateway Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$926K Sell
2,558
-1,765
-41% -$604K 0.06% 320
2026
Q1
$1.52M Buy
4,323
+2,989
+224% +$1.07M 0.06% 304
2025
Q4
$437K Buy
1,334
+157
+13% +$49.8K 0.05% 297
2025
Q3
$332K Buy
1,177
+24
+2% +$6.96K 0.04% 299
2025
Q2
$322K Buy
1,153
+345
+43% +$97.7K 0.06% 268
2025
Q1
$252K Buy
+808
New +$239K 0.06% 272

Other funds holding AMGN

Gateway Wealth Partners's AMGN Position: Q2 2026 in Review

Gateway Wealth Partners reduced its Amgen (AMGN) stake by 41% in Q2 2026, selling an estimated $604K and leaving 2,558 shares worth $926K. The position accounts for 0.06% of the portfolio, ranked #320.

Gateway Wealth Partners first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.52M in Q1 2026. 2,223 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gateway Wealth Partners held 2,558 shares of Amgen worth $926K as of Q2 2026.
  • Gateway Wealth Partners sold 1,765 Amgen shares in Q2 2026, an estimated $604K.
  • Amgen made up 0.06% of Gateway Wealth Partners's portfolio in Q2 2026, its #320 holding.
  • Gateway Wealth Partners first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Gateway Wealth Partners's Amgen position peaked at $1.52M in Q1 2026.
  • 2,223 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.